Although a decrease in the protein expression level of the ErbB4 receptor was also observed in the DM + MI group compared to the MI group (Figure 3 C), this reduction did not reach statistical significance.
← all excerpts
Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
1
—
—